Galen Holdings plc, the female pharma specialist, will post full year earnings on Tuesday.

Look for eps ~45-50pence putting the stock on an undemanding p/e of ~15. Sector average is 21, which may allow room for Galen to be re-rated.

Companys' purchase of its own stock yesterday at 690pence signifies its belief that it is currently being undervalued by the market.

Stock is currently trading at p/e of 13. With growth in earnings of 20-30% plus for the next 3-5years, PEG ratio is very low.

IMHO a great long term buy.

TSQ.

A further purchase was made of its own stock by the company at 698pence, strengthening the view that this is a good buying opportunity.

Name change on Monday to Warner Chilcott plc will give more visibilty to American NASDAQ investors.

Topped up myself, as IMHO chart, fundamentals and management all point to a higher rating.

Has he epic changed as I can not find a quote now ?

For Galen Holdings now read, Warner Chilcott (WCRX)

Company continues to buy back its own shares under 700pence.